UIH(SH:688271) Sou Hu Cai Jing·2025-12-04 12:13Core Viewpoint - The stock of United Imaging Healthcare (688271) has shown a slight decline, with significant net outflows from major and retail investors, while the company continues to demonstrate strong revenue growth and profitability metrics in the medical device industry [1][3]. Financial Performance - As of December 4, 2025, United Imaging Healthcare's stock closed at 128.87 yuan, down 0.01% with a trading volume of 22,300 hands and a transaction value of 288 million yuan [1]. - For the first three quarters of 2025, the company reported a main business revenue of 8.859 billion yuan, a year-on-year increase of 27.39%, and a net profit attributable to shareholders of 1.12 billion yuan, up 66.91% [3]. - The third quarter of 2025 alone saw a main business revenue of 2.843 billion yuan, reflecting a 75.41% year-on-year increase, and a net profit of 122 million yuan, which is a 143.8% increase compared to the same period last year [3]. Market Position and Ratios - United Imaging Healthcare has a total market value of 106.209 billion yuan, ranking second in the medical device industry, with a net asset value of 20.805 billion yuan, ranking third [3]. - The company's price-to-earnings ratio (P/E) stands at 71.11, which is higher than the industry average of 60.57, indicating a relatively high valuation compared to peers [3]. - The gross margin is reported at 47.02%, slightly below the industry average of 51.22%, while the net margin is at 12.44%, above the industry average of 9.57% [3]. Investor Sentiment - In the last 90 days, 25 institutions have rated the stock, with 18 buy ratings and 7 hold ratings, indicating a generally positive outlook among analysts [4]. - The average target price set by institutions over the past 90 days is 173.12 yuan, suggesting potential upside from the current trading price [4].